Search
ALMB-0166
go.drugbank.com/drugs/DB17937InvestigationalALMB-0166 is a umanized connexin 43 (Cx43) monoclonal antibody being investigated for the treatment of acute spinal cord injury. It was granted FDA orphan designation in November 2018.[L47067]
RPI-MN
go.drugbank.com/drugs/DB17957ExperimentalRPI-MN is a detoxified or chemically modified alpha-cobratoxin with antiviral properties.
SRP-9005
go.drugbank.com/drugs/DB17958InvestigationalSRP-9005 is a rAAVrh74 vector containing a codon-optimized human SGCG transgene.
PIKA rabies vaccine
go.drugbank.com/drugs/DB17963InvestigationalPIKA rabies vaccine is a novel vaccine developed by YS Biopharma.
HOV-12020
go.drugbank.com/drugs/DB17976InvestigationalHOV-12020 is a palm tocotrienols complex being investigated for the treatment of cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).[L47271]
MTL-CEBPA
go.drugbank.com/drugs/DB18143InvestigationalMTL-CEBPA is a SMARTICLES liposomal formulation of MTL-501, a small activating RNA (saRNA) oligonucleotide.
BRG01
go.drugbank.com/drugs/DB18173InvestigationalBRG01 is a genetically modified autologous CAR-T cell therapy under investigation for the treatment of nasopharyngeal carcinoma.[L48111]
Etavopivat
go.drugbank.com/drugs/DB18176InvestigationalEtavopivat is a small molecule activator of erythrocyte pyruvate kinase (PKR) under investigation for the treatment of sickle cell disease.
LYT-200
go.drugbank.com/drugs/DB18179InvestigationalLYT-200 is a fully human IgG4 monoclonal antibody directed against galectin-9.
ATI-1013
go.drugbank.com/drugs/DB18185InvestigationalATI-1013 is a fully human nicotine-specific monoclonal antibody.